Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario

Molecular Aspects of Medicine

Volumn 29, Issue 1-2, 2008, Pages 58-66

  Parola, Maurizio ^a   Marra, Fabio ^b   Pinzani, Massimo ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b Centro di Ricerca   (Italy)

Author keywords

Bone marrow derived mesenchymal stem cells; Fibrosis progression in chronic liver diseases; Hepatic myofibroblasts; Hepatic stellate cells; Liver Fibrogenesis; Patterns of liver fibrosis; Portal myofibroblasts; Pro fibrogenic mechanisms in liver fibrosis

Indexed keywords

REACTIVE OXYGEN METABOLITE;

BILE DUCT DISEASE; CELL INTERACTION; CELL PROLIFERATION; CHRONIC HEPATITIS; EXTRACELLULAR MATRIX; FIBROGENESIS; HEMATOPOIETIC STEM CELL; HUMAN; LIVER CELL; LIVER FIBROSIS; LIVER INJURY; MESENCHYMAL STEM CELL; MYOFIBROBLAST; OXIDATIVE STRESS; REVIEW; STELLATE CELL; TISSUE REPAIR; WOUND HEALING;

ANIMALS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FIBROBLASTS; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; REACTIVE OXYGEN SPECIES;

EID: 39749170639     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.09.002     Document Type: Review

References (59)

1. Aleffi S., Petrai I., Bertolani C., Parola M., Colombatto S., Novo E., Vizzutti F., Anania F.A., Milani S., Rombouts K., Laffi G., Pinzani M., and Marra F. Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology 42 (2005) 1339-1348
2. Albano E. Alcohol, oxidative stress and free radical damage. Proc. Nutr. Soc. 65 (2006) 278-290
3. Albano E., Mottaran E., Vidali M., Reale E., Saksena S., Occhino G., Burt A.D., and Day C.P. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 54 (2007) 987-993
4. Angulo P. Nonalcoholic fatty liver disease. New Engl. J. Med. 346 (2002) 1221-1231
5. Ankoma-Sey V., Matli M., Chang K.B., Lalazar A., Donner D.B., Wong L., Warren R.S., and Friedman S.L. Coordinated induction of VEGF receptors in mesenchymal cell types during rat hepatic wound healing. Oncogene 17 (1998) 115-121
6. Bataller R., Schwabe R.F., Choi Y.H., Yang L., Paik Y.H., Lindquist J., Qian T., Schoonhoven R., Hagedorn C.H., Leemasters J.J., and Brenner D.A. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J. Clin. Invest. 112 (2003) 1383-1394
7. Bataller R., and Brenner D.A. Liver fibrosis. J. Clin. Invest. 115 (2005) 109-118
8. Bertolani C., Sancho-Bru P., Failli P., Bataller R., Aleffi S., DeFranco R., Mazzinghi B., Romagnani P., Milani S., Gines P., Colmenero J., Parola M., Gelmini S., Tarquini R., Laffi G., Pinzani M., and Marra F. Resistin as an intrahepatic cytokine: overexpression during chronic injury and induction of proinflammatory actions in hepatic stellate cells. Am. J. Pathol. 169 (2006) 2042-2053
9. Carmeliet P. Angiogenesis in health and disease. Nat Med. 9 (2003) 653-660
10. Cassiman D., Libbrecht L., Desmet V., Denef C., and Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J. Hepatol. 36 (2002) 200-209
11. Cassiman D., and Roskams T. Beauty is in the eye of the beholder: emerging concepts and pitfalls in hepatic stellate cell research. J. Hepatol. 37 (2002) 527-535
12. Corpechot C., Barbu V., Wendum D., Kinnman N., Rey C., Poupon R., Housset C., and Rosmorduc O. Hypoxia induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology 35 (2002) 1010-1021
13. De Minicis S., Bataller R., and Brenner D.A. NADPH oxidase in the liver: defensive, offensive, or fibrogenic ?. Gastroenterology 131 (2006) 272-275
14. Desmet V.J., and Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 40 (2004) 860-867
15. Ding X., Saxena N.K., Lin S., Xu A., Srinivasan S., and Anania F.A. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am. J. Pathol. 166 (2005) 1655-1669
16. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 82 (2002) 47-95
17. Dufour J.F., DeLellis R., and Kaplan M.M. Reversibility of hepatic fibrosis in autoimmune hepatitis. Ann. Int. Med. 127 (1997) 981-985
18. El-Sharkawy A.M., Oakley F., and Mann D. The role and regulation of hepatic stellate cells apoptosis in reversal of liver fibrosis. Apoptosis 10 (2005) 927-939
19. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275 (2000) 2247-2250
20. Friedman S.L. Liver fibrosis - from bench to bedside. J. Hepatol. 38 (2003) S28-S53
21. Friedman S.L. Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pract. Gastroenterol. Hepatol. 1 (2004) 98-105
22. Friedman S.L., and Bansal M.B. Reversal of fibrosis - Fact or fantasy ?. Hepatology 43 Suppl.1 (2006) S82-S88
23. Hammel P., Couvelard A., O'Toole D., Ratouis A., Sauvanet A., Flejou J.F., Degott C., Belghiti J., Bernades P., Valla D., Ruszniewski P., and Levy P. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. Nat. Engl. J. Med. 344 (2001) 418-423
24. Iredale J.P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organism. J. Clin. Invest. 117 (2007) 539-548
25. Ikejima K., Honda H., Yoshikawa M., Hirose M., Kitamura T., Takei Y., and Sato N. Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals. Hepatology 34 (2001) 288-297
26. Kallis Y.N., Alison M.R., and Forbes S.J. Bone marrow stem cells and liver disease. Gut 56 (2007) 716-724
27. Kweon Y.O., Paik Y.H., Schnabl B., Qian T., Lemasters J.J., and Brenner D.A. Gliotoxin - mediated apoptosis of activated human hepatic stellate cells. J. Hepatol. 39 (2003) 38-46
28. Lee J.S., Semela D., Iredale J., and Shah V.H. Sinusoidal remodeling and angiogenesis: a new function for the liver-specific pericyte?. Hepatology 45 (2007) 817-825
29. 12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. J. Biol. Chem. 276 (2001) 38152-38158
30. Medina J., Caveda L., Sanz-Cameno P., Arroyo A., Martin-Vilchez S., Majano P., Garcia-Buey L., Sanchez-Madrid F., and Moreno-Otero R. Hepatocyte growth factor activates endothelial pro-angiogenic mechanisms relevant in chronic hepatitis C - associated neoangiogenesis. J. Hepatol. 38 (2003) 660-667
31. Medina J., Arroyo A.G., Sanchez-Madrid F., and Moreno-Otero R. Angiogenesis in chronic inflammatory liver disease. Hepatology 39 (2004) 1185-1195
32. Medina J., Sanz-Cameno P., Garcia-Buey L., Martin-Vilchez S., Lopez-Cabrera M., and Moreno-Otero R. Evidence of angiogenesis in primary biliary cirrhosis: an immunohistochemical descriptive study. J. Hepatol. 42 (2005) 124-131
33. Meier U., and Gressner A.M. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50 (2004) 1511-1525
34. Nieto N. Oxidative stress and IL-6 mediate the pro-fibrogenic effect of Kupffer cells on stellate cells. Hepatology 44 (2006) 1487-1501
35. Novo E., Marra F., Zamara E., Valfrè di Bonzo L., Caligiuri A., Cannito S., Antonaci C., Colombatto S., Pinzani M., and Parola M. Dose dependent and divergent effects of superoxide anion on cell death, proliferation and migration of activated human hepatic stellate cells. Gut 55 (2006) 90-97
36. Novo E., Marra F., Zamara E., Valfrè di Bonzo L., Monitillo L., Cannito S., Petrai I., Mazzocca A., Bonacchi A., De Franco R.S., Colombatto S., Autelli R., Pinzani M., and Parola M. Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. Gut 55 (2006) 1174-1182
37. Novo E., Cannito S., Zamara E., Valfrè di Bonzo L., Caligiuri A., Cravanzola C., Compagnone A., Colombatto S., Marra F., Pinzani M., and Parola M. Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells. Am. J. Pathol. (2007) 1942-1953
38. Parola M., Robino G., Marra F., Pinzani M., Bellomo G., Leonarduzzi G., Chiarugi P., Camandola S., Poli G., Waeg G., Gentilini P., and Dianzani M.U. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J. Clin. Invest. 102 (1998) 1942-1950
39. Parola M., and Robino G. Oxidative stress - related molecules and liver fibrosis. J. Hepatol. 35 (2001) 297-306
40. Pinzani M. Liver Fibrosis. Springer Semin Immunopathol 21 (2000) 475-490
41. Pinzani M., and Marra F. Cytokine receptor and signalling in hepatic stellate cells. Sem. Liv. Dis. 21 (2001) 397-417
42. Pinzani M., Romanelli R.G., and Magli S. Progression of fibrosis in chronic liver diseases - time to tally the score. J. Hepatol. 34 (2001) 764-767
43. Pinzani M., and Rombouts K. Liver fibrosis-from the bench to clinical targets. Dig. Liver Dis. 36 (2004) 231-242
44. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR and DOSVIRC groups. Lancet 349 (1997) 825-832
45. Poynard T., McHutchison J., Manns M., Trepo C., Lindsey K., Goodman Z., Ling M.H., and Albrecht J. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. Gastroenterology 123 (2002) 1061-1069
46. Purohit V., and Brenner D.A. Mechanisms of alcohol-induced hepatic fibrosis: a summary of the Ron Thurman Symposium. Hepatology 43 (2006) 872-878
47. Robertson H., Kirby J.A., Yip W.W., Jones D.E.J., and Burt A.D. Biliary epithelial-mesenchymal transition in post-transplantation recurrence of primary biliary cirrhosis. Hepatology 45 (2007) 977-981
48. Robino G., Parola M., Marra F., Caligiuri A., DeFranco R.M.S., Zamara E., Bellomo G., Gentilini P., Pinzani M., and Dianzani M.U. Interactions of 4-hydorxy-2,3-alkenals and the platelet-derived growth factor β-receptor. J. Biol. Chem. 275 (2000) 40561-40567
49. Roskams T., and Desmet V.J. Ductular reaction and its diagnostic significance. Sem. Diagn. Pathol. 15 (1998) 259-269
50. Russo F.P., Alison M.R., Bigger B.W., Amofah E., Florou A., Amin F., Bou-Gharios G., Jeffery R., Iredale J.P., and Forbes S.J. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130 (2006) 1807-1821
51. Stewart S.F., Vidali M., Day C.P., Albano E., and Jones D.E. Oxidative stress as a trigger for cellular immune response in patients with alcoholic liver disease. Hepatology 39 (2004) 197-203
52. Tilg H., and Hotamisligil G.S. Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance. Gastroenterology 131 (2006) 934-945
53. Valfrè di Bonzo, L., Ferrero, I., Cravanzola, C., Mareschi, K., Rustichelli, D., Novo, E., Sanavio, F., Cannito, S., Zamara E., Bertero, M.,Davit, A., Francica, S., Novelli, F., Colombatto, S., Fagioli, F., Parola, M., 2007. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential. Gut, published online July 16th 2007, doi:10.1136/gut.2006.111617.
54. Wanless I.R., Nakashima E., and Sherman M. Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis. Arch. Pathol. Lab. Med. 124 (2000) 1599-1607
55. Xu A., Wang Y., Keshaw H., Xu L.Y., Lam K.S., and Cooper G.J. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J. Clin. Invest. 112 (2003) 91-100
56. Yoshiji H., Kuriyama S., Yoshii J., Ikenaka Y., Noguchi R., Hicklin D.J., Wu Y., Yanase K., Namisaki T., Yamazaki M., Tsujinoue H., Imazu H., Masaki T., and Fukui H. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 52 (2003) 1347-1354
57. Zamara E., Novo E., Marra F., Gentilini A., Romanelli R.G., Caligiuri A., Robino G., Tamagno E., Aragno M., Danni O., Autelli R., Colombatto S., Dianzani M.U., Pinzani M., and Parola M. 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J. Hepatol. 40 (2004) 60-68
58. Zamara E., Novo E., and Parola M. Oxidative stress and liver fibrosis: from liver injury to modulation of cell signalling and response. In: Ali S., Friedman S.L., and Mann D. (Eds). Liver Diseases. Biochemical Mechanisms and New Therapeutic Insights Vol. 1 (2006), Science Publishers, Enfield (NH, USA) 93-114
59. Zhan S.S., Jiang J.X., Wu J., Halsted C., Friedman S.L., Zern M.A., and Torok N.J. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology 43 (2006) 435-445